GenSci134

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GenSci134, covering 2026-03-04 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) [Phase 1]